Study finds GLP-1s show potential for managing comorbid depression and anxiety

GLP-1s may offer benefits beyond managing blood sugar.

July 17, 25

Express Scripts expands Patient Assurance Program to drive affordability and access to GLP-1s

Express Scripts will add GLP-1s for weight loss to the Patient Assurance Program (PAP), made possible by collaboration with Lilly and Novo Nordisk.

July 10, 25

Evernorth Launches New Benefit Option That Drives Lower Net Cost for Weight Loss Medicines and Limits Patient Cost to No More Than $200 Per Month

• Patients can save as much as $3600 per year versus direct-to-consumer manufacturer programs, and out of pocket cost applies to their annual deductible • New offering helps employers meet growing ...

May 21, 25

New Evernorth EnReachRx model expands its suite of GLP-1 solutions, works to improve patient outcomes and drive value

May 02, 25

Podcast: Understanding GLP-1 market challenges and actionable strategies for managing impact

Listen to the latest episode of the Health Unscripted Podcast for a deep dive into the challenges and opportunities within the GLP-1 landscape.

April 22, 25

Pharmacy in Focus: Navigating GLP-1 cost, demand and sustainability

With demand and utilization expanding, comprehensive clinical support and cost-management strategies are crucial to ensuring accessibility and safeguarding health care budgets.

March 25, 25